Rare diseases
Investigational molecules
Locations
Back to Belgium1 305 clinical trials in Charleroi, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma
BelgiumStudy on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants
BelgiumStudy of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis
BelgiumStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
BelgiumStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
BelgiumStudy on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis
BelgiumStudy of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy
BelgiumStudy of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in breast cancer, lung cancer, and head and neck cancers. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials investigating personalized medicine approaches and biomarker-driven treatments.
Research examining treatments for coronary artery disease and post-cardiac arrest care. Trials focus on innovative stent technologies and antiplatelet therapy optimization.
Emphasis on improving patient outcomes through targeted interventional approaches.
Clinical investigations targeting inflammatory skin conditions and immune-mediated disorders. Studies evaluate novel treatments for psoriasis and other dermatological conditions.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
